The ATNM chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ATNM chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ATNM stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ATNM Detailed Price Forecast - CNN Money||View ATNM Detailed Summary - Google Finance|
|View ATNM Detailed Summary - Yahoo! Finance||View ATNM Stock Research & Analysis - Zacks.com|
|View ATNM Trends & Analysis - Trade-Ideas||View ATNM Major Holders - Barrons|
|View ATNM Call Transcripts - NASDAQ||View ATNM Breaking News & Analysis - Seeking Alpha|
|View ATNM Annual Report - CompanySpotlight.com||View ATNM OTC Short Report - OTCShortReport.com|
|View ATNM Fundamentals - TradeKing||View ATNM SEC Filings - Bar Chart|
|View Historical Prices for ATNM - The WSJ||View Performance/Total Return for ATNM - Morningstar|
|View the Analyst Estimates for ATNM - MarketWatch||View the Earnings History for ATNM - CNBC|
|View the ATNM Earnings - StockMarketWatch||View ATNM Buy or Sell Recommendations - MacroAxis|
|View the ATNM Bullish Patterns - American Bulls||View ATNM Short Pain Metrics - ShortPainBot.com|
|View ATNM Stock Mentions - StockTwits||View ATNM Stock Mentions - PennyStockTweets|
|View ATNM Stock Mentions - Twitter||View ATNM Investment Forum News - Investor Hub|
|View ATNM Stock Mentions - Yahoo! Message Board||View ATNM Stock Mentions - Seeking Alpha|
|View Insider Transactions for ATNM - SECform4.com||View Insider Transactions for ATNM - Insider Cow|
|View ATNM Major Holdings Summary - CNBC||View Insider Disclosure for ATNM - OTC Markets|
|View Insider Transactions for ATNM - Yahoo! Finance||View Institutional Holdings for ATNM - NASDAQ|
|View ATNM Stock Insight & Charts - FinViz.com||View ATNM Investment Charts - StockCharts.com|
|View ATNM Stock Overview & Charts - BarChart||View ATNM User Generated Charts - Trading View|
NEW YORK, March 19, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM), announced today the appointment of Mamata Gokhale, Ph.D., RAC as Vice President, Global Head of Regulatory Affairs. In this role, Dr. Gokhale will be responsible for developing and implementing a comprehensive clinical regulatory strategy across Actinium's portfolio of ARC or Antibody Radiation-Conjugate product candidates for targeted conditioning.
Actinium Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Highlights
Posted on Tuesday March 19, 2019
NEW YORK, March 19, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) reported its financial results for the fourth quarter and year ended December 31, 2018 as well as provided corporate and operational updates on clinical trials, research and development, recent hires, and intellectual property. Iomab-B is an ARC or Antibody Radiation-Conjugate that targets CD45, an antigen expressed on leukemia, lymphoma and immune cells, and delivers Iodine-131 that kills targeted cells via linear energy transfer.
Actinium Provides Comprehensive Patent Portfolio Update Including New IP Filings
Posted on Friday March 15, 2019
NEW YORK, March 15, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM), announced today that the rejuvenation of R&D activity has bolstered its patent portfolio to a total of 111 issued and pending patents in the U.S. and internationally, which is up from the 75 reported previously.
Actinium Pharmaceuticals to Present at the Oppenheimer & Co. 29th Annual Healthcare Conference
Posted on Friday March 15, 2019
- Presentation scheduled for 1:35 pm ET on Wednesday, March 20th NEW YORK , March 15, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) ("Actinium" or "the Company") ...